Central insulin-mediated regulation of hepatic glucose production [Review]

• Published in: ENDOCRINE JOURNAL Vol. 63; no. 1; pp. 1 - 7
• Main Author: Inoue, Hiroshi
• Format: Journal Article
• Language: English; Japanese
• Published: Japan The Japan Endocrine Society 2016
• Subjects: Animals; Central Nervous System - metabolism; Gluconeogenesis - drug effects; Glucose - metabolism; Humans; Hypothalamus; Insulin; Insulin - metabolism; Insulin - pharmacology; Liver; Liver - drug effects; Liver - metabolism; STAT3; Vagus nerve
• ISSN: 0918-8959; 1348-4540
• DOI: 10.1507/endocrj.EJ15-0540

Insulin controls hepatic glucose production (HGP) and maintains glucose homeostasis through the direct action of hepatic insulin receptors, as well as the indirect action of insulin receptors in the central nervous system. Insulin acts on insulin receptors in the hypothalamic arcuate nucleus, activates ATP-sensitive potassium channels in a phosphoinositide 3-kinase (PI3K)-dependent manner, induces hyperpolarization of the hypothalamic neurons, and regulates HGP via the vagus nerve. In the liver, central insulin action augments IL-6 expression in Kupffer cells and activates STAT3 transcription factors in hepatocytes. Activated STAT3 suppresses the gene expression of gluconeogenic enzymes, thereby reducing HGP. It has become evident that nutrients such as glucose, fatty acids, and amino acids act upon the hypothalamus together with insulin, affecting HGP. On the other hand, HGP control by central insulin action is impeded in obesity and impeded by insulin resistance due to disturbance of PI3K signaling and inflammation in the hypothalamus or inhibition of STAT3 signaling in the liver. Although the mechanism of control of hepatic gluconeogenic gene expression by central insulin action is conserved across species, its importance in human glucose metabolism has not been made entirely clear and its elucidation is anticipated in the future.